# Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma

> **NCT03030157** · PHASE2 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 220 (estimated)

## Conditions studied

- Intravesical Instillation

## Interventions

- **DRUG:** pirarubicin(THP)

## Key facts

- **NCT ID:** NCT03030157
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2020-01
- **Final completion:** 2020-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2019-10-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03030157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03030157, "Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03030157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*